GlassScriptPhysician profile
Erin E Peterson
NPI 1447560305
$37,404.26
in general payments reported to CMS, 2019-2025
8 companies · $13K in 2025
The $13K reported for 2025 was more than what 99% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,251 · 2022: $6,345 · 2023: $6,779 · 2024: $6,701 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,470 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,155 · Travel and Lodging: $6,884 · Food and Beverage: $1,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,470.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,155.00 |
| Travel and Lodging | $6,883.79 |
| Food and Beverage | $1,298.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $37,022.22 | 2021-2025 | Ofev |
| Astrazeneca Pharmaceuticals LP | $136.57 | 2022 | |
| Inspire Medical Systems, INC. | $104.33 | 2025 | Inspire |
| Baxter Healthcare | $39.80 | 2022 | |
| Genzyme Corporation | $39.71 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $32.57 | 2021-2024 | Dupixent |
| Myovant Sciences INC. | $15.71 | 2022 | |
| Glaxosmithkline, LLC. | $13.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Peterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.